Avadel Pharma (AVDL) Tops Q3 EPS by 11c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/29/2026

1. NOW
2. MSFT
3. GOOGL
4. FTNT
5. EBAY
6. BIIB
7. CMG
8. TENB
9. KLAC
10. ETSY

Go back to Avadel Pharma (AVDL) Tops Q3 EPS by 11c

Avadel Pharmaceuticals Reports Third Quarter 2017 Results

November 8, 2017 7:30 AM EST

Total Revenues for the Third Quarter Were $39.7 Million

Full Year Revenue Guidance of $165-$175 Million Unchanged

Acquired License for Noctiva

DUBLIN, Ireland, Nov. 08, 2017 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (NASDAQ: AVDL) today announced its financial results for the third quarter ended September 30, 2017.

Highlights Include:

Total revenues for the third quarter 2017 were $39.7 million, compared to $32.1 million in the third quarter... More